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Abstract
Resistance exercise has great potential to aid in the management of breast cancer–related lymphedema (BCRL), but little
is known regarding the acute response of performing resistance exercises with the affected limb. Purpose. To examine the
acute impact of upper body resistance exercise on the amount of swelling and severity of symptoms in women with BCRL
and to compare these effects between resistance exercise involving high and low loads (heavier vs lighter weights). Methods.
Seventeen women aged 61 ± 9 years with mild to severe BCRL participated in this study. Participants completed a high
load (6-8 repetition maximum) and low load (15-20 repetition maximum) exercise session consisting of 2 sets of 5 upper
body resistance exercises in a randomized order separated by a 10- to 12-day wash-out period. The extent of swelling was
assessed using bioimpedance spectroscopy, dual-energy x-ray absorptiometry, and arm circumference measurements. The
severity symptoms were assessed using the visual analogue scale (pain, heaviness, and tightness) and a modified Brief Pain
Inventory. Measurements were taken pre-exercise, immediately post-exercise, 24 hours post-exercise, and 72 hours postexercise. Results. No changes in the extent of swelling or the severity of symptoms were observed between pre-exercise
and immediately post-exercise, 24 hours post-exercise, or 72 hours post-exercise. No differences in the response to the
high or low load exercise were observed. Conclusions. Upper body resistance exercise does not acutely increase swelling
or feelings of discomfort/pain, heaviness tightness in the affected limb of BCRL patients when performed at either high or
low loads.
Keywords
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Introduction
Breast cancer–related lymphedema (BCRL) is the chronic
swelling of the hand, arm, shoulder, and/or breast that
occurs after treatment for breast cancer and is estimated to
affect at least 20% of breast cancer survivors.1,2 Although
the complex pathophysiology of BCRL remains unexplained, axillary lymph node removal and radiotherapy are
considered the primary initiating factors.1,3 Damage to the
lymphatic system in turn results in edema, chronic inflammation, and accumulation of tissue protein in the affected
limb.1,3 BCRL has a significant impact on quality of life.4,5
Significant physical function impairment has been reported
in both gross and fine motor tasks,1,6 as well as increased
feelings of discomfort, pain, heaviness, and aching.7
Additionally, women with BCRL exhibit significantly
increased psychosocial morbidity, including depression,
anxiety, and distress as well as displaying maladjustment to
illness.8,9 These factors permeate all aspects of life, affecting

work, home, and recreational activities as well as social
relationships.4,10
Traditionally, clinical guidelines recommend that women
with BCRL avoid vigorous, repetitive, or excessive upper
body exercise to prevent exacerbation of lymphedema.11
The conservative advice, aimed at minimizing risk of injury
or harm to the involved side, indirectly encourages women
to protect their limb, which in turn may lead them to limit
their physical activity and in particular, the use of the affected
side. However, such limitation of activity is theorized to hinder rehabilitation and in the longer term result in muscle
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atrophy, increased adiposity, and declining function.12 There
is the potential that such conservative advice is actually
counterproductive as a significant factor associated with the
decline in functional activity and quality of life in those with
BCRL appears to be a considerable loss of muscle strength
in the affected limb.13,14 Women with BCRL have significantly lower perceived and clinically measured upper body
function and are more likely to report symptoms, such as
pain, numbness, and stiffness, when compared with those
without BCRL.13,14
The overwhelming consensus throughout the literature
indicates that exercise is very beneficial for cancer patients,
resulting in clinically meaningful improvements in quality of
life, physical function, and structure as well as mental
health.15-17 A growing body of literature provides evidence
that these findings extend to patients with BCRL. A consistent finding of this research is that exercise, including exercise specifically involving the affected limb, does not appear
to initiate or exacerbate BCRL.1,11,18-24 The risk of developing
BCRL has been observed to be lower for patients who engage
in regular physical activity compared with those who are sedentary (odds ratio = 1.9; 95% confidence interval = 0.5-2.9).1
Furthermore, the incidence of BCRL was observed to be
lower in a group of breast cancer survivors involved in regular resistance exercise compared with a usual care control
group (11% vs 17%, respectively).20 The largest randomized
controlled trial involving BCRL patients to date reported no
difference over 12 months in interlimb volume difference
between women involved in resistance exercise and usual
care.21 Furthermore, the resistance exercise intervention had
beneficial effects on the incidence of exacerbations, severity
of lymphedema symptoms, and muscle strength.21
Upper body resistance exercise is emerging as a particularly important therapy for survivors with BCRL as it is
likely to support improved clearance of lymph through the
effect of the muscle pump on venous and lymphatic clearance.25-27 Increases in lean muscle mass, muscle strength,
and endurance are also expected—changes that have significant positive effects on physical functional ability.28-31
Furthermore, these changes result in an elevated maximal
work capacity, meaning that everyday tasks would require
less effort. Importantly, the increased work capacity is theorized to translate into reduced risk for lymphedema incidence and exacerbation from everyday use of the affected
arm.12 The clinical trials conducted to date provide strong
evidence that maintaining or increasing strength of the
upper body through resistance exercise aids in the management of BCRL.11,12,18-22 Despite this, a paucity of research
has examined the acute response of performing resistance
exercises with the affected limb of women with BCRL and,
most importantly, if exercise response would differ between
common prescribed resistance training loads (ie, heavier vs
lighter weights). In this study, we examined for the first
time the acute (immediately after exercise bout) impact of
upper body resistance exercise on the amount of swelling
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and severity of symptoms in women with BCRL and compared these effects between resistance exercise involving
high and low loads (ie, heavier vs lighter weights).

Methods
Participants
Sixty women with BCRL who were referred by oncologists
and physiotherapists or who responded to advertisements
via a local newspaper in the city of Perth, Western Australia
from June through August 2010, were initially screened for
participation in the study (Figure 1). Forty-three women
were excluded from participation due to declining involvement in the trial (n = 24); not meeting the criteria for clinical diagnosis of lymphedema (n = 7); physician decline
(n = 1); and other reasons (n = 11), such as travel constraints. Seventeen women were enrolled to participate in
this study. Participants had a histological diagnosis of
breast cancer at least 1 year prior to the study, a clinical
diagnosis of BCRL, and obtained medical clearance from
their physician. Clinical diagnosis of lymphedema was
defined as having (a) an impedance ratio of at least 3 standard deviations greater than normative data,32,33 (b) a volume difference between affected and unaffected limbs of
5% or more,33,34 and (c) a difference in circumference
between affected and unaffected limbs of 5% or more.21,33,34
Participants were excluded if they had (a) unstable lymphedema, defined as receiving intensive therapy (ie, decongestive therapy or antibiotics for infection) within the
previous 3 months, or (b) musculoskeletal, cardiovascular,
and/or neurological disorders that could inhibit them from
exercising. This protocol was approved by the university’s
human research ethics committee, and all participants provided written informed consent.
Sample size calculations were based on change in
lymphedema as indicated by volume and circumference (ie,
extent of swelling). Whereas a 5% change over time is considered clinically significant,21 no evidence exists regarding
the threshold for a clinically significant acute change in volume or circumference. Therefore, we aimed to detect a
medium standardized effect (d = 0.3). With an α level of .05
and a final sample of 17 patients, we achieved 80% statistical power to detect such an effect.

Experimental Design
This study involved a crossover design in which participants completed a high load and low load upper body resistance exercise session separated by a 10- to 12-day
wash-out period (Figure 1). Following comprehensive
familiarization, participants completed the exercise sessions in a randomized order. Participants were randomized
in an allocation ratio of 1:1 using a random assignment
computer program. A research methods consultant with no
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Assessed for Eligibility (n= 60)

Excluded (n = 43)
• Declined to participate (n = 24)
• Not meeting criteria for clinical
diagnosis of lymphoedema (n = 7)
• Physician decline (n = 1)
• Other reasons (n = 11)

Enrolled (n = 17)

Resistance Exercise Familiarisation Sessions (n = 17)

High Load Resistance
Exercise Session;
Pre & Post Assessments
(n = 17)

Conditions performed in a
randomised order
separated by a 10-12 day
wash-out period

Low Load Resistance
Exercise Session;
Pre & Post Assessments
(n = 17)

24 hours Post High Load
Assessment (n = 17)

24 hours Post Low Load
Assessment (n = 17)

72 hours Post High Load
Assessment (n = 17)

72 hours Post Low Load
Assessment (n = 17)

Figure 1. Flow of participants throughout trial.

patient contact was responsible for the randomization, and
the exercise physiologists involved in supervising and
assessing participants were blinded to the allocation
sequence. The extent of swelling was assessed using bioimpedance spectroscopy (BIS), dual-energy x-ray absorptiometry (DXA; limb volume), and arm circumference
measurements. The severity symptoms were assessed using
the visual analogue scale (VAS; pain, heaviness, and tightness) and a modified Brief Pain Inventory (BPI).
Measurements were taken on both the affected and nonaffected arms pre-exercise, immediately post-exercise, 24
hours post-exercise, and 72 hours post-exercise. Participants
were instructed to maintain their usual lymphedema selfcare management regimen, physical activity levels, and diet
throughout the intervention period.

Exercise Intervention
Prior to completing experimental sessions, all participants
completed a series of 4 familiarization sessions over a
2-week period. The familiarization sessions involved 1 to 2

sets of 6 to 20 repetitions of 5 upper body resistance exercises. The resistance exercises—chest press, lateral pulldown, biceps curl, triceps extension, and lateral
raise—focused on the major muscle groups in the upper
body. Symptom response was monitored using VAS for
pain, heaviness, and tightness before and after each session.35 Load was prescribed and progressed individually.
Both the high load and low load experimental exercise sessions involved moderate- to high-intensity resistance exercise. Participants were required to complete 2 sets of the 5
upper body resistance exercises. The high load session
involved lifting as much weight as possible for 6 to 8 repetitions (ie, 6-8 repetition maximum [RM]), whereas the
low load session involved lifting as much weight as possible for 15 to 20 repetitions (ie, 15-20 RM) of each exercise.31 Similar to previous research, participants choose
whether or not they wore a compression garment during the
exercise sessions,22 and this choice was held consistent
across both high and low load conditions. All sessions were
performed in an exercise clinic in individual sessions supervised by an exercise physiologist.
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Outcome Measures
The extent of swelling and the severity of symptoms were
assessed pre-exercise, immediately post-exercise, 24 hours
post-exercise, and 72 hours post-exercise for both the high
load and low load conditions. The length of time that participants wore their compression garment prior to each
assessment was recorded for all participants and held consistent for each individual across all the time points examined. Participants were asked to report any deviations from
their standard lymphedema self-care management regimen, physical activity levels, and diet at all assessment
time points.
Extent of swelling. The severity of swelling associated
with BCRL was assessed using standard objective measures: (a) BIS, (b) DXA, and (c) arm circumference measurements. These 3 methods were used as there is no gold
standard for the assessment of lymphedema and the method
used to quantify the extent of swelling may influence the
results.33,36-38 Impedance of the extracellular fluid in the
affected and non-affected arms was assessed and compared
using a range of frequencies according to guidelines of the
BIS device manufacturer (ImpediMed IMPTM DF50;
ImpediMed, San Diego, CA).32 The impedance values of
the affected and unaffected arms were compared and the
ratio reported (L-Dex score). DXA (Hologic Discovery A,
Waltham, MA) was used to assess tissue composition of the
limbs using a 3-compartment model sensitive to changes in
fluid retention.39,40 Measurements were converted into volume using known densities of adipose tissue (0.9167 g/mL
≈ 0.92 g/cm3), lean tissue (1.0615 g/mL ≈ 1.06 g/cm3), and
bone (3.15 g/cm3), a method shown to correlate very highly
(r = .996, P < .0001) with total arm volume measurement by
plethysmography.41 Absolute values of the total volume for
the affected arm as well as the volume difference between
the affected and non-affected arms were reported. A constant tension tape was used to assess regional circumferences of the affected and non-affected arms. Measurements
were started just distal to the metacarpal-phalangeal joints
and were taken at 4-cm intervals up the arm until the base of
the axilla.42 Participants were seated with their arm positioned at 90° abduction resting on a massage table while
arm circumference was assessed.33 Absolute values of the
sum of all circumference measurements for the affected arm
as well as the difference in the sum of all circumference
measurements between the affected and the non-affected
arms were reported. Circumference measurements at the
point of greatest difference between the limbs was also
assessed but not reported as the trends were consistent with
the sum of circumference measurements.
Symptom severity. The severity of BCRL symptoms was
assessed using: (a) VAS for pain, heaviness, and tightness
and (b) the BPI questionnaire. VAS were used to quantify
the severity of perceived pain, heaviness, and tightness in
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both the affected and non-affected arms.35 Participants rated
their symptom severity from no pain/no discomfort (VAS
score = 0) to very severe pain/worst imaginable discomfort
(VAS score = 10). The BPI assessed any feelings of pain,
the area of pain, the sensation (ie, discomfort, heaviness,
aching, throbbing, etc.), and the extent to which the symptoms interfered with aspects of daily life over the previous
24 hours.43 The BPI was modified so that each item was
assessed with respect to the affected and non-affected limbs
separately.21,42
Tolerance of the exercise sessions. Session rating of perceived exertion was recorded immediately after the completion of each exercise session. Participants were asked to rate
the overall difficulty of the session (ie, how hard/how much
exertion was involved) on a scale of 6 (no exertion at all) to
20 (maximal exertion). A 7-point Likert-type scale was also
administered after the completion of each exercise session
to assess the perception of tolerance of the exercise session
(1 = intolerable, 7 = very tolerable).

Statistical Analyses
Data were analyzed using SPSS Statistics for Windows,
Version 19.0 (IBM SPSS, Chicago, IL). Analyses included
standard descriptive statistics, paired sample t tests, and
repeated measures analysis of variance. All tests were
2-tailed with statistical significance set at an α level of .05.
Results are presented as mean ± standard deviation or number of participants (percentage of participants) for frequency data.

Results
Participants
All participants enrolled completed the study. Participants
had been diagnosed with lymphedema an average of 5.4
years prior to involvement in this study (Table 1).
Approximately 47% of the participants were diagnosed
within the previous 3 years. All participants had surgical
treatment (100%), with an average of 13 lymph nodes
removed during the procedure. The majority of participants
had received radiotherapy previously (88%), 65% had previous chemotherapy, and 47% previous/current hormone
therapy. Participants were generally overweight or obese
(percentage fat = 39.2 ± 5.6; body mass index = 31.5 ± 5.6
kg/m2). According to common toxicity criteria grading,34
30%, 35%, and 35% of participants had mild, moderate,
and severe lymphedema, respectively. Approximately 18%
of participants (3 of 17) chose to wear their compression
garment during the resistance exercise sessions. No deviations in standard lymphedema self-care management,
physical activity, and diet behaviors were reported throughout the study.
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Table 1. Baseline Characteristics of Participants.a

Symptom Severity

Mean ± SD or n (%)
Age (years)
Weight (kg)
Body mass index (kg/m2)
Percentage fat
No. of comorbiditiesb
No. of medications
Time since cancer diagnosis (y)
Cancer stage
I
II
III
Surgery
No. of lymph nodes removed
Radiotherapy
Chemotherapy
Hormone therapy
Time since lymphedema
diagnosis (years)
Lymphedema severity
BIS (L-Dex score)
Arm volume difference (%)
Arm circumference
difference (%)c

61.2 ± 9.1
81.0 ± 17.3
31.5 ± 6.9
39.2 ± 5.6
0.8 ± 0.7
2.4 ± 1.6
8.1 ± 9.5
8 (47)
5 (29)
4 (24)
17 (100)
13 ± 8
15 (88)
11 (65)
8 (47)
5.4 ± 5.6

23.7 ± 21.9
19.1 ± 13.9
18.7 ± 11.9

a

Results are presented as mean ± standard deviation (SD) or number of
participants (percentage of participants).
b
Comorbidity classified as cardiovascular disease, hypertension, diabetes,
osteoporosis, and dyslipidemia.
c
At the point of greatest difference between limbs.

Extent of Swelling
No significant differences were observed in volume or circumference of the affected arm across most of the time
points examined (ie, pre-exercise, immediately post-exercise,
24 hours post-exercise, and 72 hours post-exercise; Table 2).
Arm circumference at 72 hours post-high load exercise was
significantly lower that pre-exercise. When comparing the
affected and non-affected arms, no significant differences
were observed in the BIS ratio, arm volume difference, and
arm circumference difference across any of the time points
examined (Table 2). No significant changes were observed
from pre-exercise to immediately post-exercise, 24 hours
post-exercise, and 72 hours post-exercise in the BIS ratio,
arm volume, or arm circumference (Figure 2A-C). No significant differences were observed between the high load
and low load exercise conditions across all of the time
points examined (Table 2 and Figure 2A-C). There were no
clear trends in terms of the impact of the resistance exercise
on the extent of swelling, with individual responses varying
from no change to decreased and/or increased swelling
(Figure 3).

Visual analogue scale and BPI results were reported for the
affected arm only, as the difference in symptom severity
between the affected and non-affected arms did not change
throughout all time points assessed (ie, affected arm scores
were consistently significantly higher than the non-affected
arm scores across all time points for both exercise conditions). No significant differences in the severity of pain,
heaviness, or tightness were observed across all time points
examined (Table 2). Furthermore, no significant differences
in extent to which the symptoms interfered with aspects of
daily life were reported across most time points examined
(Table 2). The interference score of the BPI was significantly
lower than pre-exercise at 24 hours post-exercise, and 72
hours post–low load exercise (Table 2). No significant
changes were observed from pre-exercise to immediately
post-exercise, 24 hours post-exercise, and 72 hours post-exercise
in the severity of pain, heaviness, or tightness (Figures 2D-F).
No significant differences were observed between the high
load and low load exercise conditions across all of the time
points examined (Table 2, Figure 2D-F). No clear trends
existed in the symptom response to the exercise conditions as
individual responses varied from no change to decreased and/
or increased severity of pain, heaviness, and tightness following the exercise sessions (Figure 4).

Tolerance of the Exercise Sessions
Compliance was high with all participants completing all
required exercise and assessment sessions (100% compliance). No adverse events were recorded. The moderate- to
high-intensity resistance exercise resulted in a rating of
perceived exertion of approximately 12.5 ± 1.3, which is
equivalent to a rating of “somewhat hard” (high load =12.6
± 1.3; low load =12.3 ± 1.2). The exercise sessions were
well tolerated with an average tolerance score of 6.7 ± 0.6
out of a possible 7 (high load = 6.8 ± 0.4; low load =6.7 ±
0.6). No differences in the rating of perceived exertion or
tolerance existed between the high and low load resistance
exercise sessions. The weight lifted differed significantly
between the high load and low load conditions (high load
=33.3 ± 4.7 kg; low load =21.5 ± 3.1 kg; P = .000).

Discussion
The primary findings of this small, exploratory study
includes the following: (a) upper body resistance exercise
performed in a controlled setting (ie, correct instruction and
highly supervised) did not acutely increase the extent of
swelling or the severity of symptoms in women with
BCRL; (b) there was no difference in the acute response to
upper body resistance exercise involving either high loads
(6-8 RM) or low loads (15-20 RM); and (c) the moderate- to
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Table 2. Extent of Swelling and Severity of Symptoms Throughout All Conditions.a
Pre-exercise

Post-exercise

24 Hours Post-exercise

BIS (L-Dex score)
High load
22.9 ± 22.2
22.6 ± 20.9
Low load
24.5 ± 21.8
24.4 ± 22.9
Affected arm volume (mL)
High load
4283.8 ± 1163.3
4306.3 ± 1150.0
Low load
4253.6 ± 1103.6
4269.1 ± 1105.3
Volume difference between affected and non-affected arms (mL)
High load
601.4 ± 571.5
645.2 ± 593.9
Low load
604.8 ± 559.4
628.8 ± 551.5
Affected arm circumference (cm)
High load
195.0 ± 34.5
194.7 ± 33.8
Low load
192.6 ± 28.7
192.2 ± 28.5
Circumference difference between affected and non-affected arms (cm)
High load
15.2 ± 11.6
15.1 ± 11.2
Low load
15.2 ± 10.8
14.9 ± 11.0
VAS—Pain (score)
High load
0.7 ± 1.3
1.0 ± 1.4
Low load
1.0 ± 2.2
1.4 ± 2.0
VAS—Heaviness (score)
High load
1.3 ± 1.8
1.2 ± 1.5
Low load
1.3 ± 2.4
1.8 ± 2.0
VAS—Tightness (score)
High load
1.3 ± 1.5
1.6 ± 2.1
Low load
1.3 ± 2.0
1.7 ± 1.9
BPI—Pain (score)
High load
1.6 ± 2.0
1.8 ± 1.6
Low load
1.9 ± 2.0
2.2 ± 1.5
BPI—Interference (score)
High load
Low load

1.6 ± 1.6
1.7 ± 1.6

72 hours Post-exercise

23.1 ± 20.8
24.4 ± 20.9

23.2 ± 21.7
23.0 ± 21.0

4264.0 ± 1123.9
4267.2 ± 1095.4

4312.9 ± 1161.2
4247.2 ± 1098.4

576.8 ± 577.8
541.2 ± 573.8

667.2 ± 595.4
635.7 ± 577.1

194.3 ± 34.0
192.3 ± 28.4

193.9 ± 33.4b
191.7 ± 28.4

14.9 ± 11.5
15.2 ± 11.1

12.8 ± 10.5
14.7 ± 11.4

0.6 ± 0.9
0.7 ± 1.3

0.7 ± 1.5
0.5 ± 0.9

1.0 ± 1.5
1.3 ± 1.8

1.2 ± 1.9
1.0 ± 1.5

1.1 ± 1.2
1.3 ± 1.9

1.1 ± 1.5
1.1 ± 1.4

1.4 ± 1.4
1.3 ± 1.4c

1.6 ± 2.0
1.4 ± 1.7c

1.2 ± 1.3
1.0 ± 1.2b

1.2 ± 1.5
1.1 ± 1.5b

—
—

a

Visual analogue scale (VAS) and Brief Pain Inventory (BPI) scores are from the affected arm. No post-exercise measure for BPI—Interference
(it assesses interference with activities of daily living in the past 24 hours).
b
Significantly different from pre-exercise.
c
Significantly different from post-exercise.
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Figure 2. Change in the extent of swelling (A-C) and severity of symptoms (D-F) from pre-exercise to immediately post-exercise, 24
hours post-exercise, and 72 hours post-exercise for both high and low load conditions.
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Figure 3. Individual response in the extent of swelling from pre-exercise to immediately post-exercise, 24 hours post-exercise and 72
hours post-exercise for both high (A-C) and low (D-F) load conditions.
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Figure 4. Individual response in the severity of symptoms from pre-exercise to immediately post-exercise, 24 hours post-exercise, and
72 hours post-exercise for both high (A-C) and low (D-F) load conditions.
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high-intensity upper body resistance exercise sessions
involving high (6-8 RM) and low (15-20 RM) loads were
well tolerated by women with BCRL.
Despite the common advice for women with BCRL to
avoid lifting with their affected limb to prevent an exacerbation, the upper body resistance exercise performed in a
controlled setting during this study did not acutely increase
the extent of swelling or the severity of lymphedema symptoms. This is the first investigation to examine the impact
of moderate- to high-intensity upper body resistance exercise on the affected limb of women with BCRL immediately after and in the days following an exercise session.
The methodologies involved with the assessment of swelling were among the most comprehensive used to date,33
with changes in extracellular fluid, arm volume, and arm
circumference measured both in absolute terms as well as
the difference between affected and non-affected arms. The
lack of significant change in any of these measures, coupled with the observation that pain, heaviness, tightness,
and the degree to which BCRL symptoms interfered with
aspects of daily life did not worsen following the exercise
suggests that appropriately prescribed and supervised
resistance exercise is safe for women with BCRL. These
findings support previous research examining the acute
impact of low intensity resistance exercises targeting arm
muscles in patients with mild to moderate BCRL.44
Furthermore, the current findings add to an emerging body
of evidence indicating that regular upper body resistance
exercise is safe and does not cause exacerbations in women
with BCRL.19-23
The current results provide initial evidence indicating
that the load (high 6-8 RM or low 15-20 RM) used during
upper body resistance exercise performed in a controlled
setting did not affect the acute response in swelling or
symptom severity in this sample of women with BCRL. It is
well established that both high (generally ≥80% of 1 RM)
and low (generally ≤60% 1 RM) load resistance exercise
are effective at eliciting physiological adaptations that
translate into improved muscle size, strength, and physical
function (provided the intensity of the resistance exercise is
moderate-high).28,30,31,45,46 However, a strong dose-response
relationship exists between the load of resistance training
and the magnitude of muscle size and strength gains.30,31,46,47
For example, a meta-analysis of 140 trials indicates maximal gains in strength are observed with high load resistance
exercise (80% of 1 RM effect size = 1.80 ± 1.30) compared
with lower loads (eg, 70% of 1 RM effect size = 0.70 ±
0.65).46 Importantly, a strong dose-response relationship
exists between strength gains and improvements in physical
function following resistance training,30 and high load resistance exercise has also been reported to result in significantly greater improvements in health-related quality of life
when compared with low load resistance exercise.48 Despite
the evidence for superior efficacy of high load resistance
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exercise, clinical experience indicates that women with
BCRL are very apprehensive about using heavier weights,
and allied health professionals who advise patients to exercise typically stipulate low intensity exercise using very
light loads.44 Results from the current study indicate that
there was no difference in the acute response in swelling or
symptom severity between high and low loads. Although
continued study is required to determine the long-term
effect, this initial evidence indicates that an appropriately
designed and supervised upper body resistance exercise
program involving the prescription of high loads was safe
for women with BCRL and may lead to superior long-term
improvements in physical structure and function.
Moderate- to high-intensity upper body resistance exercise was well tolerated by women with BCRL. Additionally,
there was no difference in the perceived difficulty or tolerability of the resistance exercise sessions involving either
the low or high loads. This is an important outcome to highlight, given the apprehension commonly experience by
women with BCRL to participate in an exercise program
involving upper body resistance exercise and the distribution of patients with mild, moderate, and severe lymphedema within this study. There is theoretical rationale12 and
evidence19-23 that resistance exercise is an effective adjunct
therapy for the management of BCRL. Our current study
extends these findings indicating that both low and high
loads are well tolerated by this patient population when
appropriately prescribed and supervised.
There are limitations associated with this investigation
worthy of comment. Although the sample size provided
adequate power to detect a medium standardized effect (d =
0.3), the relatively small number of participants limited the
ability to detect changes of a small standardized effect (d =
0.1-0.29). It is unclear what magnitude of effect is clinically
significant when examining acute changes in lymphedema
severity, so the results should be interpreted with caution.
Due to the fact that assessments were taken up to 72 hours
after the exercise sessions, the results at both 24 hours postexercise and 72 hours post-exercise may have been confounded by the other activities participants were involved in
after the exercise bout (eg, mopping, gardening, etc.).
However, participants were instructed to maintain normal
daily activities throughout the duration of the study.
Although every effort was made to ensure consistency in
the length of time, participants wore their compression garment prior to each assessment point; self-report may have
differed from actual behavior. The relatively small sample
size prevents any subgroup analysis required to examine if
the response to the exercise bouts differed according to
lymphedema severity. However, this was the first exploratory study examining different exercise loads, and we
employed a comprehensive battery of measures to assess
lymphedema swelling and symptom severity including BIS,
DXA, arm circumference, VAS (pain, heaviness, and
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tightness), and the BPI questionnaire. Finally, our subjects
were well-functioning individuals who were mostly motivated to undertake the exercise study, and they may not be
representative of all women with BCRL.

Conclusions
This exploratory, acute study suggests that when appropriately prescribed and supervised, women with BCRL can
perform moderate- to high-intensity upper body resistance
exercise with both low and high loads without fear of exacerbating their lymphedema. Furthermore, this type of exercise was well tolerated by a sample of women with BCRL,
and we report no adverse events. These initial findings have
important clinical significance, given the clear potential for
resistance exercise to aid in the long-term management of
BCRL through enhanced muscular strength and endurance
as well as improved functional ability. Prospective trials
examining the chronic response of upper body resistance
exercise using low and high loads are warranted.
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